Prnewswireยท2025-11-20 13:13Core Insights - Hoth Therapeutics, Inc. has been accepted into the NVIDIA Connect Program, enhancing its capabilities in AI-powered research and development [1][2][4] Group 1: NVIDIA Connect Program Benefits - The acceptance into the NVIDIA Connect Program provides Hoth Therapeutics with access to accelerated computing resources, technical guidance, and marketing support [2][4] - This partnership is expected to streamline Hoth's R&D strategy, reducing computational bottlenecks and enhancing predictive modeling [3][4] Group 2: Strategic Implications - The collaboration with NVIDIA is anticipated to improve the speed and efficiency of Hoth's drug-development programs, particularly in preclinical and clinical decision-making [4][7] - Hoth will utilize NVIDIA's GPU-accelerated developer tools to enhance computational biology workflows, including target identification and protein-structure modeling [7] Group 3: Company Overview - Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments aimed at improving patient quality of life [5] - The company employs a patient-centric approach, collaborating with scientists and clinicians to explore therapeutics with significant potential [5]